We interviewed 23 applicants, then of those 23 applicants we passed four, and then two of those withdrew within less than a ...

“This is a fundamental building block to future research opportunities so we're very proud of our families for getting us to this point,” she ... Life Sciences Summit West is coming to San ...

The New York Legislature honored the U.S. Military Academy during the 73rd annual West Point Day in Albany on April 9 at the State Capitol Building in Albany, New York. State Sen. James Skoufis ...

Behind declines for shares of Merck and Goldman Sachs, the Dow Jones Industrial Average is declining Wednesday morning. Supported by world-class markets data from Dow Jones and FactSet ...

The Dow Jones Industrial Average is declining Wednesday morning with shares of Amgen and Merck seeing the biggest losses for the price-weighted average. Supported by world-class markets data from ...

Merck & Co. is handing over $200 million to China’s Hengrui Pharma for a phase 2-stage lipoprotein(a) (Lp(a)) inhibitor. In return for the ex-China rights to the drug, dubbed HRS-5346, Merck has ...

The stock of Merck MRK has declined 19.2% in the past six months, losing almost $52 billion of its market value The numerous challenges plaguing the company resulted in the dilution of the stock ...

Merck has recently achieved a significant milestone with the European Commission's approval of its pneumococcal vaccine CAPVAXIVE®, boosting its portfolio in the vaccines market. Despite this ...

Merck's stock trades at a low valuation as investors worry about Keytruda's looming patent cliff. The company is looking to a new, subcutaneous formulation, which could help sales remain strong ...

As a final point, we may note that Merck pays an annual dividend that presently yields ~3.4%. This is a nice bonus for shareholders and at the more generous end of the “Big Pharma” spectrum.

Merck licenses the protein, called berahyaluronidase alfa, from Alteogen. Merck has filed a petition with the U.S. Patent and Trademark Office to challenge seven of Halozyme’s patents.

Comprising five downtown city blocks, the mixed-use Market West development revitalizes the former DuPont headquarters into six distinct properties. BPG acquired the Nemours building, Brandywine ...